eLife (Oct 2015)
Precise let-7 expression levels balance organ regeneration against tumor suppression
- Linwei Wu,
- Liem H Nguyen,
- Kejin Zhou,
- T Yvanka de Soysa,
- Lin Li,
- Jason B Miller,
- Jianmin Tian,
- Joseph Locker,
- Shuyuan Zhang,
- Gen Shinoda,
- Marc T Seligson,
- Lauren R Zeitels,
- Asha Acharya,
- Sam C Wang,
- Joshua T Mendell,
- Xiaoshun He,
- Jinsuke Nishino,
- Sean J Morrison,
- Daniel J Siegwart,
- George Q Daley,
- Ng Shyh-Chang,
- Hao Zhu
Affiliations
- Linwei Wu
- Children's Research Institute, Departments of Pediatrics and Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, United States; Organ Transplant Center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China; Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, United States
- Liem H Nguyen
- Children's Research Institute, Departments of Pediatrics and Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, United States; Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, United States
- Kejin Zhou
- Simmons Comprehensive Cancer Center, Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, United States
- T Yvanka de Soysa
- Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, United States; Harvard Stem Cell Institute, Harvard University, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States; The Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Boston Children’s Hospital, Boston, United States
- Lin Li
- Children's Research Institute, Departments of Pediatrics and Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, United States; Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, United States
- Jason B Miller
- Simmons Comprehensive Cancer Center, Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, United States
- Jianmin Tian
- Department of Pathology, University of Pittsburg, Pittsburg, United States
- Joseph Locker
- Department of Pathology, University of Pittsburg, Pittsburg, United States
- Shuyuan Zhang
- Children's Research Institute, Departments of Pediatrics and Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, United States; Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, United States
- Gen Shinoda
- Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, United States; Harvard Stem Cell Institute, Harvard University, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States; The Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Boston Children’s Hospital, Boston, United States
- Marc T Seligson
- Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, United States; Harvard Stem Cell Institute, Harvard University, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States; The Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Boston Children’s Hospital, Boston, United States
- Lauren R Zeitels
- Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, United States; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, United States
- Asha Acharya
- Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, United States; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, United States
- Sam C Wang
- Children's Research Institute, Departments of Pediatrics and Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, United States; Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, United States; Department of Surgery, University of Texas Southwestern Medical Center, Dallas, United States
- Joshua T Mendell
- Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, United States; Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, United States
- Xiaoshun He
- Organ Transplant Center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
- Jinsuke Nishino
- Howard Hughes Medical Institute, Children's Research Institute, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States
- Sean J Morrison
- Howard Hughes Medical Institute, Children's Research Institute, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, United States
- Daniel J Siegwart
- ORCiD
- Simmons Comprehensive Cancer Center, Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, United States
- George Q Daley
- Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, United States; Harvard Stem Cell Institute, Harvard University, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States; The Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Boston Children’s Hospital, Boston, United States
- Ng Shyh-Chang
- Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana Farber Cancer Institute, Boston, United States; Harvard Stem Cell Institute, Harvard University, Boston, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States; The Manton Center for Orphan Disease Research, Howard Hughes Medical Institute, Boston Children’s Hospital, Boston, United States; Stem cell and Regenerative Biology, Genome Institute of Singapore, Singapore, Singapore
- Hao Zhu
- Children's Research Institute, Departments of Pediatrics and Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, United States; Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, United States
- DOI
- https://doi.org/10.7554/eLife.09431
- Journal volume & issue
-
Vol. 4
Abstract
The in vivo roles for even the most intensely studied microRNAs remain poorly defined. Here, analysis of mouse models revealed that let-7, a large and ancient microRNA family, performs tumor suppressive roles at the expense of regeneration. Too little or too much let-7 resulted in compromised protection against cancer or tissue damage, respectively. Modest let-7 overexpression abrogated MYC-driven liver cancer by antagonizing multiple let-7 sensitive oncogenes. However, the same level of overexpression blocked liver regeneration, while let-7 deletion enhanced it, demonstrating that distinct let-7 levels can mediate desirable phenotypes. let-7 dependent regeneration phenotypes resulted from influences on the insulin-PI3K-mTOR pathway. We found that chronic high-dose let-7 overexpression caused liver damage and degeneration, paradoxically leading to tumorigenesis. These dose-dependent roles for let-7 in tissue repair and tumorigenesis rationalize the tight regulation of this microRNA in development, and have important implications for let-7 based therapeutics.
Keywords